All News

    Robotic Kidney Cancer Surgery May Aid Recovery, Spare Kidney Function

    May 15th 2025, 8:00pm

    Video

    Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, according to Dr. Armine Smith.

    FDA Approves Zynyz Treatment Regimen for Advanced Anal Cancer

    May 15th 2025, 7:27pm

    Article

    The FDA has approved Zynyz as a first-line treatment in combination with chemo and as a single-agent following progression in advanced anal cancer.

    Finding Comfort in Teddy Bears Throughout My Experience With CLL

    May 15th 2025, 5:00pm

    Article

    As a patient with CLL, I’ve found comfort in teddy bears — first as a chaplain offering solace, now as a patient embracing their quiet presence myself.

    Ventana MET RxDx Assay Receives FDA Approval as Companion Diagnostic in NSCLC

    May 15th 2025, 4:00pm

    Article

    The FDA approved the Ventana MET RxDx assay, making it the first companion diagnostic to aid in determining MET protein expression in non-squamous NSCLC.

    Efti Plus Keytruda With Chemo Shows High Response in NSCLC Subset

    May 15th 2025, 3:00pm

    Article

    Efti plus Keytruda and chemo achieved a 61% response rate in first-line advanced non-squamous non–small cell lung cancer, outperforming historical data.

    Lumakras Plus Vectibix Shows Potential in KRAS G12C Colorectal Cancer

    May 15th 2025, 1:00pm

    Article

    Lumakras plus Vectibix showed improved overall survival and response rates in KRAS G12C metastatic colorectal cancer, though not statistically significant.

    CX-2051 Proves Safe and Effective in Advanced Colon Cancer

    May 14th 2025, 9:00pm

    Article

    CX-2051 treatment demonstrated responses in patients with advanced, late-line colorectal cancer, according to interim data from the CTMX-2051-101 study.

    Long-Term Prostate Cancer Data Highlights Risk and Survivorship Needs

    May 14th 2025, 8:00pm

    Video

    Researchers followed patients for years and found that the risk of dying from prostate cancer depended on how aggressive the cancer was at diagnosis.

    FDA Approves Emrelis in Previously Treated, Advanced NSCLC

    May 14th 2025, 6:36pm

    Article

    The U.S. FDA has approved treatment with Emrelis for adult patients with previously treated, advanced NSCLC with high c-Met protein overexpression.

    Survivors of Breast Cancer May Still Struggle with Fear of Recurrence

    May 14th 2025, 6:00pm

    Article

    Even after many cancer-free years, the fear of recurrence still lingers, and many long-term survivors struggle to keep those thoughts at bay.